• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

机器学习在西班牙临床实验室数据中应用于 COVID-19 结局预测:模型的开发和验证。

Machine Learning Applied to Clinical Laboratory Data in Spain for COVID-19 Outcome Prediction: Model Development and Validation.

机构信息

Higher Technical School of Engineering, University of Huelva, Huelva, Spain.

Juan Ramón Jiménez University Hospital, Huelva, Spain.

出版信息

J Med Internet Res. 2021 Apr 14;23(4):e26211. doi: 10.2196/26211.

DOI:10.2196/26211
PMID:33793407
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8048712/
Abstract

BACKGROUND

The COVID-19 pandemic is probably the greatest health catastrophe of the modern era. Spain's health care system has been exposed to uncontrollable numbers of patients over a short period, causing the system to collapse. Given that diagnosis is not immediate, and there is no effective treatment for COVID-19, other tools have had to be developed to identify patients at the risk of severe disease complications and thus optimize material and human resources in health care. There are no tools to identify patients who have a worse prognosis than others.

OBJECTIVE

This study aimed to process a sample of electronic health records of patients with COVID-19 in order to develop a machine learning model to predict the severity of infection and mortality from among clinical laboratory parameters. Early patient classification can help optimize material and human resources, and analysis of the most important features of the model could provide more detailed insights into the disease.

METHODS

After an initial performance evaluation based on a comparison with several other well-known methods, the extreme gradient boosting algorithm was selected as the predictive method for this study. In addition, Shapley Additive Explanations was used to analyze the importance of the features of the resulting model.

RESULTS

After data preprocessing, 1823 confirmed patients with COVID-19 and 32 predictor features were selected. On bootstrap validation, the extreme gradient boosting classifier yielded a value of 0.97 (95% CI 0.96-0.98) for the area under the receiver operator characteristic curve, 0.86 (95% CI 0.80-0.91) for the area under the precision-recall curve, 0.94 (95% CI 0.92-0.95) for accuracy, 0.77 (95% CI 0.72-0.83) for the F-score, 0.93 (95% CI 0.89-0.98) for sensitivity, and 0.91 (95% CI 0.86-0.96) for specificity. The 4 most relevant features for model prediction were lactate dehydrogenase activity, C-reactive protein levels, neutrophil counts, and urea levels.

CONCLUSIONS

Our predictive model yielded excellent results in the differentiating among patients who died of COVID-19, primarily from among laboratory parameter values. Analysis of the resulting model identified a set of features with the most significant impact on the prediction, thus relating them to a higher risk of mortality.

摘要

背景

COVID-19 大流行可能是现代史上最大的健康灾难。西班牙的医疗保健系统在短时间内面临着无法控制的大量患者,导致系统崩溃。鉴于诊断并非即时,且 COVID-19 目前尚无有效治疗方法,因此必须开发其他工具来识别有发生严重疾病并发症风险的患者,从而优化医疗保健的物资和人力资源。目前还没有工具可以识别预后比其他患者更差的患者。

目的

本研究旨在处理一组 COVID-19 患者的电子健康记录,以开发一种机器学习模型来预测感染严重程度和死亡率,预测依据是临床实验室参数。早期对患者进行分类有助于优化物资和人力资源,对模型最重要特征的分析可以提供更详细的疾病见解。

方法

在基于与其他几种知名方法的比较进行初步性能评估后,选择极端梯度提升算法作为本研究的预测方法。此外,使用 Shapley 加法解释来分析所得模型的特征重要性。

结果

在数据预处理后,选择了 1823 名确诊 COVID-19 患者和 32 个预测特征。在引导验证中,极端梯度提升分类器在接收者操作特征曲线下的面积为 0.97(95%置信区间 0.96-0.98),在精度-召回曲线下的面积为 0.86(95%置信区间 0.80-0.91),准确度为 0.94(95%置信区间 0.92-0.95),F 分数为 0.77(95%置信区间 0.72-0.83),灵敏度为 0.93(95%置信区间 0.89-0.98),特异性为 0.91(95%置信区间 0.86-0.96)。对模型预测最重要的 4 个特征是乳酸脱氢酶活性、C 反应蛋白水平、中性粒细胞计数和尿素水平。

结论

我们的预测模型在区分 COVID-19 死亡患者方面取得了优异的结果,主要依据是实验室参数值。对所得模型的分析确定了一组对预测影响最大的特征,从而与更高的死亡率相关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b72d/8048712/270b8ea5c471/jmir_v23i4e26211_fig6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b72d/8048712/b3ebc64fcd63/jmir_v23i4e26211_fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b72d/8048712/a61e8051c137/jmir_v23i4e26211_fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b72d/8048712/d93b5cc6820f/jmir_v23i4e26211_fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b72d/8048712/d23d0a47e9c3/jmir_v23i4e26211_fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b72d/8048712/dd677707aff7/jmir_v23i4e26211_fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b72d/8048712/270b8ea5c471/jmir_v23i4e26211_fig6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b72d/8048712/b3ebc64fcd63/jmir_v23i4e26211_fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b72d/8048712/a61e8051c137/jmir_v23i4e26211_fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b72d/8048712/d93b5cc6820f/jmir_v23i4e26211_fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b72d/8048712/d23d0a47e9c3/jmir_v23i4e26211_fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b72d/8048712/dd677707aff7/jmir_v23i4e26211_fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b72d/8048712/270b8ea5c471/jmir_v23i4e26211_fig6.jpg

相似文献

1
Machine Learning Applied to Clinical Laboratory Data in Spain for COVID-19 Outcome Prediction: Model Development and Validation.机器学习在西班牙临床实验室数据中应用于 COVID-19 结局预测:模型的开发和验证。
J Med Internet Res. 2021 Apr 14;23(4):e26211. doi: 10.2196/26211.
2
Development and External Validation of a Machine Learning Tool to Rule Out COVID-19 Among Adults in the Emergency Department Using Routine Blood Tests: A Large, Multicenter, Real-World Study.利用常规血液检测排除急诊科成人COVID-19的机器学习工具的开发与外部验证:一项大型、多中心、真实世界研究
J Med Internet Res. 2020 Dec 2;22(12):e24048. doi: 10.2196/24048.
3
Using Automated Machine Learning to Predict the Mortality of Patients With COVID-19: Prediction Model Development Study.利用自动化机器学习预测 COVID-19 患者的死亡率:预测模型开发研究。
J Med Internet Res. 2021 Feb 26;23(2):e23458. doi: 10.2196/23458.
4
Machine Learning to Predict Mortality and Critical Events in a Cohort of Patients With COVID-19 in New York City: Model Development and Validation.机器学习预测纽约市新冠肺炎患者队列中的死亡率和危急事件:模型开发与验证
J Med Internet Res. 2020 Nov 6;22(11):e24018. doi: 10.2196/24018.
5
Construction and validation of a machine learning-based nomogram: A tool to predict the risk of getting severe coronavirus disease 2019 (COVID-19).基于机器学习的列线图的构建与验证:预测 2019 年冠状病毒病(COVID-19)重症风险的工具。
Immun Inflamm Dis. 2021 Jun;9(2):595-607. doi: 10.1002/iid3.421. Epub 2021 Mar 13.
6
The Development and Validation of Simplified Machine Learning Algorithms to Predict Prognosis of Hospitalized Patients With COVID-19: Multicenter, Retrospective Study.中文译文:简化机器学习算法预测 COVID-19 住院患者预后的开发和验证:多中心回顾性研究。
J Med Internet Res. 2022 Jan 21;24(1):e31549. doi: 10.2196/31549.
7
Prognostic Assessment of COVID-19 in the Intensive Care Unit by Machine Learning Methods: Model Development and Validation.通过机器学习方法对重症监护病房中新冠肺炎的预后评估:模型开发与验证
J Med Internet Res. 2020 Nov 11;22(11):e23128. doi: 10.2196/23128.
8
Prediction and Feature Importance Analysis for Severity of COVID-19 in South Korea Using Artificial Intelligence: Model Development and Validation.利用人工智能预测和分析韩国 COVID-19 严重程度及特征重要性:模型建立与验证。
J Med Internet Res. 2021 Apr 19;23(4):e27060. doi: 10.2196/27060.
9
Clinical and inflammatory features based machine learning model for fatal risk prediction of hospitalized COVID-19 patients: results from a retrospective cohort study.基于临床和炎症特征的机器学习模型对住院 COVID-19 患者死亡风险的预测:一项回顾性队列研究的结果。
Ann Med. 2021 Dec;53(1):257-266. doi: 10.1080/07853890.2020.1868564.
10
Prediction of Sepsis in COVID-19 Using Laboratory Indicators.利用实验室指标预测 COVID-19 中的脓毒症。
Front Cell Infect Microbiol. 2021 Mar 2;10:586054. doi: 10.3389/fcimb.2020.586054. eCollection 2020.

引用本文的文献

1
The critical effects of self-management strategies on predicting cancer survivors' future quality of life and health status using machine learning techniques.自我管理策略对运用机器学习技术预测癌症幸存者未来生活质量和健康状况的关键影响。
PLoS One. 2025 Aug 28;20(8):e0330570. doi: 10.1371/journal.pone.0330570. eCollection 2025.
2
Utilizing machine learning to predict hospital admissions for pediatric COVID-19 patients (PrepCOVID-Machine).利用机器学习预测儿科新冠病毒肺炎患者的住院情况(PrepCOVID-机器学习)
Sci Rep. 2025 Jan 24;15(1):3131. doi: 10.1038/s41598-024-80538-4.
3
Predictive modelling and identification of critical variables of mortality risk in COVID-19 patients.

本文引用的文献

1
Admission hyperglycaemia as a predictor of mortality in patients hospitalized with COVID-19 regardless of diabetes status: data from the Spanish SEMI-COVID-19 Registry.无论患者是否患有糖尿病,住院 COVID-19 患者的入院高血糖症可预测其死亡率:来自西班牙 SEMI-COVID-19 登记处的数据。
Ann Med. 2021 Dec;53(1):103-116. doi: 10.1080/07853890.2020.1836566.
2
Machine Learning to Predict Mortality and Critical Events in a Cohort of Patients With COVID-19 in New York City: Model Development and Validation.机器学习预测纽约市新冠肺炎患者队列中的死亡率和危急事件:模型开发与验证
J Med Internet Res. 2020 Nov 6;22(11):e24018. doi: 10.2196/24018.
3
2019冠状病毒病患者死亡风险的预测建模及关键变量识别
Sci Rep. 2025 Jan 16;15(1):2184. doi: 10.1038/s41598-023-46712-w.
4
Machine learning based predictive modeling and risk factors for prolonged SARS-CoV-2 shedding.基于机器学习的预测模型和 SARS-CoV-2 延长脱落的风险因素。
J Transl Med. 2024 Nov 22;22(1):1054. doi: 10.1186/s12967-024-05872-7.
5
Improving prediction of COVID-19 mortality using machine learning in the Spanish SEMI-COVID-19 registry.利用西班牙 SEMI-COVID-19 注册研究中的机器学习改进对 COVID-19 死亡率的预测。
Intern Emerg Med. 2023 Sep;18(6):1711-1722. doi: 10.1007/s11739-023-03338-0. Epub 2023 Jun 22.
6
Predicting intubation risk among COVID-19 hospitalized patients using artificial neural networks.使用人工神经网络预测新冠肺炎住院患者的插管风险。
J Educ Health Promot. 2023 Jan 31;12:16. doi: 10.4103/jehp.jehp_20_22. eCollection 2023.
7
Comprehensive analysis of clinical data for COVID-19 outcome estimation with machine learning models.使用机器学习模型对COVID-19结果估计的临床数据进行综合分析。
Biomed Signal Process Control. 2023 Jul;84:104818. doi: 10.1016/j.bspc.2023.104818. Epub 2023 Mar 9.
8
Lethality risk markers by sex and age-group for COVID-19 in Mexico: a cross-sectional study based on machine learning approach.墨西哥 COVID-19 按性别和年龄组划分的致死风险标志物:基于机器学习方法的横断面研究。
BMC Infect Dis. 2023 Jan 11;23(1):18. doi: 10.1186/s12879-022-07951-w.
9
Predicting Risk of Mortality in COVID-19 Hospitalized Patients using Hybrid Machine Learning Algorithms.使用混合机器学习算法预测新冠肺炎住院患者的死亡风险
J Biomed Phys Eng. 2022 Dec 1;12(6):611-626. doi: 10.31661/jbpe.v0i0.2105-1334. eCollection 2022 Dec.
10
Clinlabomics: leveraging clinical laboratory data by data mining strategies.临床实验室组学:通过数据挖掘策略利用临床实验室数据。
BMC Bioinformatics. 2022 Sep 24;23(1):387. doi: 10.1186/s12859-022-04926-1.
Clinical Predictive Models for COVID-19: Systematic Study.
新型冠状病毒肺炎的临床预测模型:系统研究
J Med Internet Res. 2020 Oct 6;22(10):e21439. doi: 10.2196/21439.
4
Developing a COVID-19 mortality risk prediction model when individual-level data are not available.在无法获得个体层面数据时开发 COVID-19 死亡率风险预测模型。
Nat Commun. 2020 Sep 7;11(1):4439. doi: 10.1038/s41467-020-18297-9.
5
Prediction of Type 2 Diabetes Risk and Its Effect Evaluation Based on the XGBoost Model.基于XGBoost模型的2型糖尿病风险预测及其效果评估
Healthcare (Basel). 2020 Jul 31;8(3):247. doi: 10.3390/healthcare8030247.
6
Machine Learning Model for Risk Prediction of Community-Acquired Acute Kidney Injury Hospitalization From Electronic Health Records: Development and Validation Study.基于电子健康记录的社区获得性急性肾损伤住院风险预测的机器学习模型:开发和验证研究。
J Med Internet Res. 2020 Aug 4;22(8):e16903. doi: 10.2196/16903.
7
From Local Explanations to Global Understanding with Explainable AI for Trees.利用可解释人工智能实现从局部解释到树木的全局理解
Nat Mach Intell. 2020 Jan;2(1):56-67. doi: 10.1038/s42256-019-0138-9. Epub 2020 Jan 17.
8
Acute Hyperglycemic Crises with Coronavirus Disease-19: Case Reports.伴有新型冠状病毒肺炎的急性高血糖危象:病例报告。
Diabetes Metab J. 2020 Apr;44(2):349-353. doi: 10.4093/dmj.2020.0091.
9
Incidence of thrombotic complications in critically ill ICU patients with COVID-19.COVID-19 重症监护病房危重症患者的血栓并发症发生率。
Thromb Res. 2020 Jul;191:145-147. doi: 10.1016/j.thromres.2020.04.013. Epub 2020 Apr 10.
10
Hematologic, biochemical and immune biomarker abnormalities associated with severe illness and mortality in coronavirus disease 2019 (COVID-19): a meta-analysis.与 2019 年冠状病毒病(COVID-19)严重疾病和死亡相关的血液学、生物化学和免疫生物标志物异常:荟萃分析。
Clin Chem Lab Med. 2020 Jun 25;58(7):1021-1028. doi: 10.1515/cclm-2020-0369.